Back to Global Biotech page

Finglobedirect offers Investor Presentations published by global biotech companies. These Investor Presentations are compiled by companies to provide strategic input about their business activities along with focus on their financial performance parameters. We provide Investor Presentations (IPs) for global biotech companies grouped by various categories for 25 or 50 companies so then users can obtain these presentations right away rather than going through 1,000 listed companies in the global biotech sector.

Coverage: We have reviewed the most recent 400+ Investor Presentations complied by the global biotech companies. Though most of these Investor Presentations were prepared to highlight annual or quarterly earnings of companies, there were many also prepared for a given investor conference or a trade conference or special events set up by companies to provide a strategic view to investors.

Categories of Investor Presentations Available:

Global Global BigCap 50 ( Mktcap US$1billion and above) Global MidCap 50 ( Mktcap $250m to $1billion) Global Small Cap 50 (Mktcap $50m to $250m) Global Micro Cap 50 (Mktcap $5m and to $50m) Global Medical Devices 50 Global Medical Technology 50 Global Medical Supplies 50 Multinationals 50 R&D Intensive 50 M&A Focused 50 Diversified 50 US/Canada US/Canada BigCap 50 ( Mktcap US$1billion and above) US/Canada MidCap 50 ( Mktcap $250m to $1billion) US/Canada SmallCap 50 (Mktcap $50m to $250m) US/Canada Medical Devices 50 US/Canadal Medical Technology 50 US/Canada Medical Supplies 50 US/Canada Multinationals 50 US/Canada R&D Intensive 50 US/Canada M&A Focused 50 US/Canada Diversified 50 Asia Asia BigCap 25 Asia MidCap25 Asia SmallCap 25 Asia Medical Devices 25 Asia Medical Technology 25 Asia Medical Supplies 25 Asia Multinationals 25 Asia R&D Intensive 25 Asia M&A Focused 25 Asia Diversified 25 Europe Europe BigCap 25 Europe MidCap 25 Europe SmallCap 25 Europe Medical Devices 25 Europe Medical Technology 25 Europe Medical Supplies 25 Europe Multinationals 25 Europe R&D Intensive 25 Europe M&A Focused 25 Europe Diversified 25

Subscription Fees:

$295 for 50 Investor Presentations - Global 50
$295 for 50 Investor Presentations - US/Canada 50
$195 for 25 Investor Presentations - Asia 25
$195 for 25 Investor Presentations - Europe 25

Please send us an email for any further queries to info@finglobedirect.com

Select Product $295 for Global 50 Investor Presentations $295 for US/Canada 50 Investor Presentations $195 for Asia 25 Investor Presentations $195 for Europe 25 Investor Presentations

Select Price $295 $195

$950 for all three publications: Global Biotech series on Analysis/Investors Presentations (savings of $245)

• Global Biotech Business: Recent Growth and New Directions $500
• Global Biotech 500: Analysis of Quarterly Earnings (3rd Quarter 2015) $400
• Global Biotech: Investor Presentations( 50 companies) $295

Select Product Global Biotech series on Analysis/Investors Presentations

Select Price $950

Please send us an email for any further queries to info@finglobedirect.com.